Retinitis Pigmentosa is a specific type of eye disease that affects the retina. It's a genetic condition that causes the retina to slowly break down over time. This breakdown starts with the rod cells, which help you see in low light, and then affects the cone cells, which help you see colors and details.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Retinitis pigmentosa (RP) is a group of rare, mostly inherited eye diseases in which the light-sensing cells of the retina, the thin layer of tissue at the back of the eye, slowly break down. As those cells are lost, vision fades gradually over years, usually in both eyes. The first sign is typically trouble seeing at night or in dim light, often beginning in childhood or the teenage years. Next, blind spots appear at the edges of vision and slowly join up, narrowing side (peripheral) vision until only a central window remains, often called tunnel vision. Central vision, which handles reading, driving and recognizing faces, is usually affected later. Some people also become sensitive to bright light or lose some color vision. The age at which symptoms start and the speed of change vary widely, even within one family. In about 20 to 30 percent of people, RP is part of a wider genetic syndrome. The most common is Usher syndrome, which combines RP with hearing loss that begins early in life.
Most RP is caused by changes (variants) in genes that the retina's light-sensing cells need to work and survive. More than 130 genes are known to be involved. The retina has two kinds of these cells: rods, which work in low light, and cones, which handle daylight, detail and color. In RP the rods usually fail first, which is why night vision goes before daytime and color vision. RP can be passed down in several ways. In dominant forms, one altered copy from one parent is enough, so most people with these forms have an affected parent. In recessive forms, a person inherits an altered copy from each parent, and the parents usually have no symptoms themselves. In X-linked forms, males are mainly affected, although some female carriers also develop vision loss. Because of these patterns, not everyone with RP has a known family history. Less commonly, changes that look like RP come from certain medicines, infections or an eye injury rather than inherited genes.
RP is usually diagnosed by an eye doctor through a dilated eye exam, in which drops widen the pupils so the retina can be examined. A visual field test maps how far a person can see to the sides and shows where blind spots have formed. Repeating it over time is one of the main ways to track change. Other tests show how the retina is working. Electroretinography (ERG) measures the retina's electrical response to flashes of light, much as an electrocardiogram records the heart's electrical activity. Optical coherence tomography (OCT) takes detailed cross-section images of the retina, and fundus autofluorescence imaging uses light to show areas of damaged tissue. Genetic testing can often identify the gene responsible, though a cause is found in only about half to four in five people. Knowing the gene can help predict how vision may change, shows whether gene therapy or a clinical trial is an option, and clarifies the chance of passing RP on. A genetic counselor can explain those results for the person and their relatives.
There is no cure for most forms of RP, and no treatment yet restores the retinal cells that have been lost. Care focuses on making the most of remaining vision, treating problems that add to vision loss, and, for a small number of people, gene therapy. Low vision services are central. A low vision specialist can recommend magnifiers, strong lighting, high-contrast settings, and other devices, and rehabilitation (training) programs teach practical ways to keep reading, working and getting around as vision changes. Two common eye problems in RP can be treated. Cataracts, a clouding of the lens, may be removed surgically, which helps some people. Cystoid macular edema, small pockets of fluid in the central retina, can blur reading vision. Carbonic anhydrase inhibitors, medicines that help move fluid out of the retina, given as eye drops (such as dorzolamide) or tablets (such as acetazolamide), can reduce this swelling, as can steroid implants placed in the eye. These reduce swelling more reliably than they produce lasting gains in sharpness. For people with confirmed changes in both copies of a gene called RPE65 who still have living retinal cells, the gene therapy voretigene neparvovec (Luxturna) is approved by the US Food and Drug Administration (FDA). It delivers a working copy of the gene through surgery under the retina, one eye at a time. In its main trial, treated people could move around more accurately in dimmer light. It applies only to this specific genetic form, and as with other retinal surgery it carries risks including infection, cataract and, uncommonly, permanent loss of sharpness. Vitamin A and fish oil (DHA) supplements have been studied for slowing RP, but whether they help is uncertain, and too much vitamin A can damage the liver. Discuss them with an eye doctor rather than starting them alone. Gene, cell and drug treatments for other forms are being studied in clinical trials.
RP is a lifelong condition that usually progresses slowly over many years, and the pace depends largely on the gene involved. Many people reach the level of vision loss called legal blindness by adulthood, but most do not lose all sight. Early on, the main challenges are moving around in dim places, adjusting from light to dark, and missing things off to the side, such as bumping into objects, steps or people. Driving at dusk and at night usually becomes difficult first, and narrowing side vision eventually affects whether a person can drive safely at all. Later, if central vision is affected, reading and recognizing faces become harder. Planning ahead for transportation, work adjustments and vision rehabilitation helps people stay independent as needs change. Regular eye exams matter even though RP itself cannot be reversed, because they catch treatable problems such as cataracts and macular edema and track how vision is changing. Knowing the genetic cause also keeps the door open to new treatments and clinical trials as they emerge. Many people find practical and emotional support through low vision programs and RP or Usher syndrome communities.
See an eye doctor if a child or adult has trouble seeing at night, takes a long time to adjust to darkness, or keeps bumping into things to the side, and especially if RP runs in the family. People with RP benefit from regular follow-up, and a referral for genetic testing, genetic counseling or low vision services is worth asking for at any stage. Arrange a sooner visit if reading vision becomes blurry or distorted, since this can signal macular edema or a cataract, both of which can be treated. RP normally changes slowly, so flashes of light, a sudden increase in floaters or any sudden change in vision is different and needs medical care right away, the same day.
Last reviewed • Oct 2026
Educational content, not medical advice.
I was formally diagnosed in May of 2026, but I started experiencing symptoms around 2018 at the age of 38. I know there's no treatment or cure, so I'm coming here to see what other visual aids, tricks, or accessories have helped you navigate the world daily. Currently, I'm looking for sunglasses and looking to see what shade made the most difference. I've been reading a lot about amber, brown, and red, so anyone who's tried a lot of different colors, care to chime in?